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Using ultrasound, magnetic resonance imaging, or radiation
i.e.  ventriculogram or computed tomography) with acceleration
f  CPU or GPU speed development, the cardiovascular anatomical
nd  functional imaging modalities have matured and been clini-
ally  available in advanced countries in this century. The apparent
mages  or movies by the “New world” techniques can visualize as
f we are seeing the heart or valve directly like a ‘fantastic voy-
ge’,  and estimated data (valvular area, etc.) from them are now
bsolutely  necessary for our clinical decisions.
In the current Case Report [1] of the Journal, the authors have
eported  the case of a 16-year-old who suffered rheumatic heart
isease  (“an old world disease”), which was successfully diag-
osed  with 2D transthoracic echocardiography (2D-TTE), 2D and
D transesophageal echocardiography (2D-, 3D-TEE), and cardiac
agnetic  resonance imaging (CMR). The authors have reported the
sefulness of such a multimodality strategy in the clinical arena.
The  2D-TTE image quality obtained from the apical and
arasternal window was reasonable, and the transmitral Doppler
ignal  was adequately clear, so that it seemed sufﬁcient to reach a
nal conclusion for the pathological condition and severity of the
itral stenosis of the patient. The recently well-matured method
f  3D-TTE was not used regrettably. The 2D-TEE had essentially the
ame information as the 2D-TTE, but the 3D-TTE image was beauti-
ul.  The authors thoroughly performed CMR  to know the etiology of
he left ventricular dysfunction and conﬁrm the “anatomical struc-
ure” of the mitral valve (just mentioned as commissural fusion
n  the text) for the “additional information” to their surgeon for
itral  valve replacement (not repair). Because the surgical ﬁnd-
ng  or surgeons’ comments were not included in the report, the
additional  information” (which would be critically important) was
nfortunately unclear after the successful procedure.
In the “New world”, we may  have the luxury of choice for med-
cal  imaging studies. This means that we have to think what is
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odality  well. These features include accuracy, reliability, avail-
bility,  particular ability (merit/demerit, advantage/disadvantage,
r strength/weakness of each one), approximate time required,
nvasiveness, versatility, and cost.
Versatility sounds respectable; ‘one-size ﬁts all’ is very conve-
ient  and might be ideal. CMR  might provide all information we
nd  the patients need, it is based on less time-resolution, and high
ost  [2]. In reality, such versatility may  not matter, because we can
martly apply a couple of modalities in a mutually complemen-
ary  manner. There is no point in striving for mastery (e.g. MRI  is
uperior to echocardiography). We  have to maximize accuracy, and
eliability; and have to minimize time required, invasiveness, and
ost. One modality avoids the need for all purpose. Besides no one
an perform CMR  and computed tomography frequently or serially.
2D-TTE  is always the ﬁrst-line examination that we  perform
aily.  The “old world” modality actually works well mostly. The
roblem  is when the ﬁrst one does not work and we could not
each  enough conclusions (could not make clinical decision), and
hen what imaging modality we  should use next. This is a common
ccurrence  in Asian populations due to the narrower intercostal
pace  than western ones. However, performing all modalities is
pparently too much for patient management.
Atrial ﬁbrillation remains an inherent problem and should over-
ome  all 3D imaging modalities to make images align completely.
elatively higher simple 2D-TTE may  provide useful and important
nformation  in this situation.
The ability to detect mural thrombi in the left atria, appendage,
nd  ventricle with TEE is certainly superior to the transthoracic
pproach. Information about the existence of intracardiac throm-
us  is also important when surgery is planned. What about when
EE  or CMR  indicate no thrombi in the heart? An experienced sur-
eon would view this with caution. They operate the procedures
ith  much caution in case thrombi may  be there. So we are never
ble  to say that there is not a thrombus; we  can only say there is or
t  could not be observed at the time of the study.
For several cardiovascular diseases, in guidelines initiated by
merican  academic societies, a consensus of experts has sug-
ested  adequate use of multimodalities [3,4]. Regarding valvular
eart  disease, it seems that many investigators contributed to
aluable  articles for establishing this [5–11], which would lead
s  to the most affordable strategy in each clinical scenario.
iscordance in estimated valvular area (irrespective of valvular
tenosis  or incompetence) would be expected; the estimated value
vier Ltd. All rights reserved.
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[Editorial / Journal of Card
ith the transvalvular velocity-approach and direct measurement
planimetry) should be different. As we know, aortic and mitral
alves  behave quite dynamically [12], to image those adequate
ime-resolution is necessary. A major weakness of the echocar-
iographic approach may  be imaging of the tricuspid valve and
ight  atria and ventricle. That may  be game time of CMR  or com-
uted  tomography. We  have to know the habits of each modality
lthough,  it seems that the most imperative issue is providing
eneﬁt to the patients rather than desiring ultimate accurate mea-
urement of the valvular area. Overestimation of stenosis should
e  avoided, and of regurgitant area may  be accepted, because as a
ate-keeper it should raise an alarm rather than missing it.
The  “additive information” for the surgeons’ making preoper-
tive  tactics is also of great interest. Their thoughts (what the
urgeons  would like to know before the cardiac surgery) should
e  sufﬁciently reﬂected in the guidelines.
There is only one mission for all cardiac modalities; which is
o  provide beneﬁts for patient’s symptoms and survival. If patients
ould  have the full beneﬁt, that is enough. For the patients’ beneﬁts,
e  working in the “New world” would perform them necessarily
nd  sufﬁciently, not using all of those that we have.
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